Prospective clinical study of serum vitamin C level on risk of differentiated thyroid carcinoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042304

Enrollment

Unknown

Registered

2021-01-17

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated thyroid carcinoma

Interventions

Observation group:Nil

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients admitted with suspected differentiated thyroid carcinoma.

Exclusion criteria

Exclusion criteria: Patients admitted to hospital mainly diagnosed with diseases of other organs.

Design outcomes

Primary

Measure	Time frame
Serum vitamin C;	—

Countries

China

Contacts

Public ContactChuanjia Yang

Shengjing Hospital Affiliated to China Medical University

cjyang@cmu.edu.cn+86 18940255801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026